| Mark P Amico, MD | |
|
18460 Roscoe Blvd Fl 3, Northridge, CA 91325-4107 | |
| (818) 885-5480 | |
| (818) 993-1917 |
| Full Name | Mark P Amico |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 40 Years |
| Location | 18460 Roscoe Blvd Fl 3, Northridge, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508968603 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | G56952 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northridge Hospital Medical Center | Northridge, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dignity Health Medical Foundation | 7810800661 | 1209 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
In Pakistan, one of only three nations worldwide where polio remains endemic, "rumors and conspiracy theories about the vaccine ... have helped the country maintain its unenviable status," recording 91 cases of the disease in 2011, Agence France-Presse reports.
Extremely premature infants who screen positive for autism spectrum disorder at 18 months of age may not actually have autism. Rather, they may fail screening tests due to an unrelated cognitive or language delay, according to research to be presented Sunday, May 1, at the Pediatric Academic Societies annual meeting in Denver.
OSI Pharmaceuticals, Inc. will fully redeem on April 21, 2010 all of its remaining outstanding 3.25% Convertible Senior Subordinated Notes due 2023 pursuant to the terms of the indenture under which the Notes were issued in September 2003. The aggregate principal amount currently outstanding of the Notes is $60,467,000. The CUSIP number for these Notes is 671040 AD 5.
› Verified 1 days ago
| Entity Name | Dignity Health Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700803418 PECOS PAC ID: 7810800661 Enrollment ID: O20031107000709 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
In Pakistan, one of only three nations worldwide where polio remains endemic, "rumors and conspiracy theories about the vaccine ... have helped the country maintain its unenviable status," recording 91 cases of the disease in 2011, Agence France-Presse reports.
Extremely premature infants who screen positive for autism spectrum disorder at 18 months of age may not actually have autism. Rather, they may fail screening tests due to an unrelated cognitive or language delay, according to research to be presented Sunday, May 1, at the Pediatric Academic Societies annual meeting in Denver.
OSI Pharmaceuticals, Inc. will fully redeem on April 21, 2010 all of its remaining outstanding 3.25% Convertible Senior Subordinated Notes due 2023 pursuant to the terms of the indenture under which the Notes were issued in September 2003. The aggregate principal amount currently outstanding of the Notes is $60,467,000. The CUSIP number for these Notes is 671040 AD 5.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark P Amico, MD 3400 Data Dr, Rancho Cordova, CA 95670-7956 Ph: () - | Mark P Amico, MD 18460 Roscoe Blvd Fl 3, Northridge, CA 91325-4107 Ph: (818) 885-5480 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
In Pakistan, one of only three nations worldwide where polio remains endemic, "rumors and conspiracy theories about the vaccine ... have helped the country maintain its unenviable status," recording 91 cases of the disease in 2011, Agence France-Presse reports.
Extremely premature infants who screen positive for autism spectrum disorder at 18 months of age may not actually have autism. Rather, they may fail screening tests due to an unrelated cognitive or language delay, according to research to be presented Sunday, May 1, at the Pediatric Academic Societies annual meeting in Denver.
OSI Pharmaceuticals, Inc. will fully redeem on April 21, 2010 all of its remaining outstanding 3.25% Convertible Senior Subordinated Notes due 2023 pursuant to the terms of the indenture under which the Notes were issued in September 2003. The aggregate principal amount currently outstanding of the Notes is $60,467,000. The CUSIP number for these Notes is 671040 AD 5.
› Verified 1 days ago
Dr. Prathima Smruthi Charugundla, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 548-081-8885 Fax: 818-993-1917 | |
Amber Kristy Williams, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 818-885-5480 Fax: 818-993-1917 | |
Shadi Sharif, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 818-885-5480 Fax: 818-993-1917 | |
Dr. Sandeep Chadha, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 818-885-5480 Fax: 818-993-1917 | |
Michael E Damavandi, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 818-885-5480 Fax: 818-993-1917 | |
Marta Beth Almli, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 818-885-5480 Fax: 818-993-1917 | |
Dr. Lesley Prince, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 18460 Roscoe Blvd Fl 3, Northridge, CA 91325 Phone: 818-885-5480 Fax: 818-993-1917 |